CD40.HVac

N/A

Report date: 2025/04/18 15:19:30

Base Information

Drug NameCD40.HVac
Drug Alias NameHPV anti-CD40 HPV vaccineAnti-CD40 HPV vaccineCD40.HVacHPV CD40 HVac
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOropharyngeal NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLinKinVax
China Registration ClassN/A

Develop Information

Active CompaniesLinKinVax
Inactive CompaniesN/A
Active IndicationsOropharyngeal NeoplasmsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A